Year
DEALS // DEV.
Country
Therapeutic Area
Study Phase
Deal Type
Product Type
Dosage Form
Lead Product
Target
Lead Product(s) : Hyaluronic Acid,Coriolus Versicolor
Therapeutic Area : Infections and Infectious Diseases
Study Phase : Approved
Sponsor : Biovaxys
Deal Size : Undisclosed
Deal Type : Agreement
BioVaxys and Procare Health Execute US Distribution Agreement for Papilocare Gel and Oral Immunocaps
Details : Papilocare (hyaluronic acid) vaginal gel is the first treatment that has been scientifically proven to have a very high success rate in eliminating not only the human papiloma virus (HPV), but also precancerous lesions of the cervix.
Brand Name : Papilocare
Molecule Type : Small molecule
Upfront Cash : Undisclosed
December 19, 2022
Lead Product(s) : Hyaluronic Acid,Coriolus Versicolor
Therapeutic Area : Infections and Infectious Diseases
Highest Development Status : Approved
Sponsor : Biovaxys
Deal Size : Undisclosed
Deal Type : Agreement
LOOKING FOR A SUPPLIER?